When does the Nephrocare IPO open and close?

The Nephrocare IPO opens for subscription on December 10 and closes on December 12.

What is Nephrocare's business model?

Nephrocare operates an asset-light, capital-efficient model, with over half of its clinics using revenue-sharing arrangements.

What is Nephrocare's market share in India?

Nephrocare holds over 50% share of the organized dialysis services market in India.

Home / Business and Economy / Nephrocare IPO: Dialysis Giant Aims for ₹871 Crore

Nephrocare IPO: Dialysis Giant Aims for ₹871 Crore

10 Dec

•

Summary

Nephrocare, India's largest dialysis provider, launches ₹871 crore IPO.
Company operates an asset-light model with 52.4% clinics on revenue sharing.
Net profit doubled in FY25 to ₹67 crore; revenue rose 33.5%.

Nephrocare IPO: Dialysis Giant Aims for ₹871 Crore

Nephrocare Health Services, India's largest dialysis provider, is set to launch its ₹871 crore Initial Public Offering (IPO) from December 10 to December 12. The company, which operates the NephroPlus brand, has secured ₹260 crore from anchor investors ahead of the launch.

Following an asset-light and capital-efficient model, 52.4% of its clinics operate on revenue-sharing, minimizing investment in space. Nephrocare's financial performance shows robust growth, with net profit nearly doubling to ₹67 crore in the fiscal year 2025 and revenue increasing by 33.5% to ₹755.8 crore.

The IPO aims to raise ₹353.4 crore through a fresh issue, with proceeds allocated to opening new clinics in India and debt repayment. Promoters and existing investors will also sell shares through an offer for sale. The company has a significant presence, with 519 clinics globally, including 51 international centers.